Carlumab

Generic Name: Carlumab

Brand Names: -

Drug Type: Biotech

Chemical Formula: -

CAS Number: 915404-94-3

Unique Ingredient Identifier: 6TC1BB2EV9

Background: Carlumab has been used in trials studying the treatment of Cancer and Prostate Cancer.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Breakthrough Mirror-Image Monobody Targets MCP-1 For Therapy

Innovative mirror-image monobodies, made from D-amino acids, offer new potential in protein-based drug development, targeting diseases linked with MCP-1. Utilizing TRAP display, researchers developed D-monobodies with high specificity, binding affinity, and proteolytic resistance, marking a significant advancement in therapeutic agent development.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy